Yahoo Entertainment on Nostr: Indian drugmakers to see FY25 revenue boost in key US market, says India Ratings and ...
Indian drugmakers to see FY25 revenue boost in key US market, says India Ratings and Research
==========
Indian drugmakers, including Dr Reddy's, Cipla, and Sun Pharma, are expected to see a revenue boost in the fiscal year 2025 in the key US market due to drug shortages. The US market is currently facing a shortage of 233 drugs across 22 therapeutic categories, leading to rising demand and delays in shipments. The shortage is attributed to the discontinuation of production of certain drugs by US-based generic pharma manufacturers and increasing regulatory costs. Indian companies are expected to fill the gap by expanding supply chains and increasing participation across therapeutic categories. Additionally, price erosion in the US market is expected to fall to single digits in the next 12 to 18 months, improving returns for drugmakers.
#IndianDrugmakers #UsMarket #RevenueBoost #DrugShortages #DrReddy's #Cipla #SunPharma
https://www.yahoo.com/news/indian-drugmakers-see-fy25-revenue-102203858.html
==========
Indian drugmakers, including Dr Reddy's, Cipla, and Sun Pharma, are expected to see a revenue boost in the fiscal year 2025 in the key US market due to drug shortages. The US market is currently facing a shortage of 233 drugs across 22 therapeutic categories, leading to rising demand and delays in shipments. The shortage is attributed to the discontinuation of production of certain drugs by US-based generic pharma manufacturers and increasing regulatory costs. Indian companies are expected to fill the gap by expanding supply chains and increasing participation across therapeutic categories. Additionally, price erosion in the US market is expected to fall to single digits in the next 12 to 18 months, improving returns for drugmakers.
#IndianDrugmakers #UsMarket #RevenueBoost #DrugShortages #DrReddy's #Cipla #SunPharma
https://www.yahoo.com/news/indian-drugmakers-see-fy25-revenue-102203858.html